CHU d'Amiens

Amiens 80054

0 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Indolent Systemic Mastocytosis

Studies at this site

• BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab — Stopped early
• Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis — Completed